Clinical Trials Browser

Phase EARLY_PHASE1 × Nivolumab × Thoracic × Clear all

NCT03224871 2020-04-07

UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung

NCT03371992 2020-03-27

NO3DEXPL

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung